View PHARMExcel to exhibit at 10th Annual Outsourcing in Clinical Trials UK and Ireland

PHARMExcel to exhibit at 10th Annual Outsourcing in Clinical Trials UK and Ireland

Visit PHARMExcel at OCT UK and Ireland and hear real world evidence into innovations and industry trends that you cannot afford to miss.

Read More

View PHARMExcel welcomes new MHRA Corporate Plan 2023-2026

PHARMExcel welcomes new MHRA Corporate Plan 2023-2026

PHARMExcel welcomes new risk-proportionate regulations and priority regulatory pathways in MHRA Corporate Plan 2023-2026

Read More

View Collaboration is Key – Learnings from UKCRF Network’s 18th Annual Conference

Collaboration is Key – Learnings from UKCRF Network’s 18th Annual Conference

Learn how collaboration is key to accelerating research to clinical trial stage and other key insights from the UK CRFN conference

Read More

View PHARMExcel joins forces with BIA to expand biotech horizons

PHARMExcel joins forces with BIA to expand biotech horizons

PHARMExcel joins forces with the BIA.

Read More

View PHARMExcel to attend UKCRFN Annual Conference 2023

PHARMExcel to attend UKCRFN Annual Conference 2023

Read More

View Case study: Liver dialysis device, DIALIVE, proves safe and effective

Case study: Liver dialysis device, DIALIVE, proves safe and effective

Read More

View PHARMExcel announces publication of its COV-BOOST paper in Journal of Infection

PHARMExcel announces publication of its COV-BOOST paper in Journal of Infection

We’re proud of our vital vaccine trial work, leading the way in prevention and control of infectious diseases

Read More

View Secukinumab in Behcet’s Trial: Working Towards a Promising Breakthrough for a Rare Autoimmune Condition

Secukinumab in Behcet’s Trial: Working Towards a Promising Breakthrough for a Rare Autoimmune Condition

Read More

View PHARMExcel sponsors NHS R&D Forum 2023

PHARMExcel sponsors NHS R&D Forum 2023

Join over 700 experts at the annual NHS Research and Development Forum conference in association with the Health Research Authority.

Read More